Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Influenza B nucleoprotein is the primary structural and functional component of the viral ribonucleoprotein (RNP) complex in Influenza B viruses, essential for viral RNA encapsidation and for the regulation of both transcription and replication of the viral genome[1][2][4]. It forms homo-oligomers through tail-loop insertions, binds viral RNA in an electropositive groove, and shuttles the RNP complex into the host nucleus via a nuclear localization signal located in its extended N-terminal region[1][2][3]. The nucleoprotein is highly conserved within influenza B viruses but possesses an N-terminal extension distinguishing it from influenza A nucleoprotein, and this extension is critical for viral viability and nuclear import[2][3]. Because of its central role in viral replication, it is an attractive target for antiviral drug development and a reliable diagnostic marker for infection[2].
Inhibition of nucleoprotein blocks viral RNA encapsidation, thereby impairing genome replication and transcription[1][2] - Disruption of nuclear import prevents replication complex assembly[3]
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Influenza B nucleoprotein (NP (for nucleoprotein)).